The Neural Correlates of Cannabis Use
NCT03104257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162
Last updated 2025-10-21
Summary
The purpose of this research study is to determine the temporal course of recovery of CB1R availability and neural oscillations, in cannabis-dependent individuals at baseline, following 48 hour confirmed inpatient abstinence and after four weeks confirmed abstinence. This research will also examine associations between CB1R availability, neural oscillations and cognitive function.
Conditions
- Cannabis Dependence
- Healthy
Interventions
- DRUG
-
[11-C]OMAR
The radiotracer, \[11-C\]OMAR will be administered at no more than 10 micrograms at the beginning of each PET scan.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Mohini Ranganathan, MD · Yale University
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2022-04-27
- Completion
- 2022-04-27
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Varenicline Treatment for Cannabis Use Disorder
NCT02892110 ·Status: COMPLETED ·Phase: PHASE2
-
SV2A Density Cannabis Use Disorder
NCT05472818 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effects of THC on Alcohol Consumption and Neural Correlates of Reward
NCT06446479 ·Status: RECRUITING ·Phase: PHASE2
-
Neuroscience of Alcohol and Marijuana Impaired Driving
NCT03431987 ·Status: UNKNOWN
-
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
NCT03253926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cannabis Effects on Brain Morphology in Aging
NCT01874886 ·Status: COMPLETED
-
Cerebellar Alterations in Individuals With a Cannabis Use Disorder
NCT02816034 ·Status: COMPLETED ·Phase: NA
-
Nabilone for Cannabis Dependence: A Pilot Study
NCT01347762 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Imaging Cannabinoid CB1 Receptors in Alcohol Dependence
NCT00816439 ·Status: COMPLETED
-
Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients
NCT02913924 ·Status: COMPLETED ·Phase: PHASE2
-
Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
NCT05859347 ·Status: RECRUITING ·Phase: NA
-
Using Imaging to Assess Effects of THC on Brain Activity
NCT03655717 ·Status: COMPLETED ·Phase: NA
-
Effect of Baclofen on Marijuana Withdrawal and Relapse
NCT00373295 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
NCT01618656 ·Status: COMPLETED ·Phase: PHASE2
-
Cannabidiol and Cannabis Concentrate Users
NCT06575751 ·Status: RECRUITING ·Phase: PHASE2
-
Ketamine/Placebo Family History Positive Study
NCT00588952 ·Status: COMPLETED ·Phase: NA
-
Brain Neurochemical Profile During Marijuana Abstinence
NCT04320537 ·Status: COMPLETED
-
Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
NCT00218517 ·Status: COMPLETED ·Phase: PHASE2
-
Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse
NCT02616094 ·Status: COMPLETED ·Phase: NA
-
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
NCT05855668 ·Status: RECRUITING ·Phase: NA
-
Combined Pharmacotherapy for Cannabis Dependency
NCT01020019 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Family History Study of Alcohol Consumption Using Memantine
NCT00630955 ·Status: COMPLETED ·Phase: PHASE2
-
Neural Correlates of Driving and Cannabis
NCT03581058 ·Status: UNKNOWN ·Phase: PHASE1
-
Dronabinol Treatment for Marijuana Addiction
NCT00217971 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence
NCT02210195 ·Status: COMPLETED ·Phase: PHASE2